In Brief: Perrigo
This article was originally published in The Tan Sheet
Executive Summary
Perrigo: Private label naproxen sodium will ship Jan. 12, one day after exclusivity for Aleve expires, in 24-, 50- and 100-count bottles of 220 mg tablets or capsules. Perrigo's ANDA received FDA approval Oct. 4 on the heels of Granutec's August approval ("The Tan Sheet" Sept. 9, p. 4). Roche's Aleve generated sales of $136.4 mil. for the 52 weeks ended July 28, Information Resources, Inc. reports...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning